<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To explore the relationship between the <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) and <z:hpo ids='HP_0002960'>autoimmune disorders</z:hpo> (AID) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: The clinical data of 117 MDS patients were reviewed </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: Nineteen (16.2%) of 117 MDS patients had AIDs </plain></SENT>
<SENT sid="3" pm="."><plain>The commonest AID associated with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> was <z:hpo ids='HP_0001370'>rheumatoid arthritis</z:hpo> (31.6%) and <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> (26.3%) </plain></SENT>
<SENT sid="4" pm="."><plain>Compared with that in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients without <z:hpo ids='HP_0002960'>autoimmune disorders</z:hpo>, the leukemic transformation rate was not increased in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>/AID but the median survival time was shorter in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>/AID patients </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSION: <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients associated with <z:hpo ids='HP_0002960'>autoimmune disorders</z:hpo> may be an unfavorable factor for their prognosis </plain></SENT>
</text></document>